Our research presents compelling evidence that assessing cytokine concentrations, specifically IL-8 and VEGF, can be useful in predicting hematological complications such as lymphopenia, neutropenia, anemia, infection, and polyneuropathy in MM patients. Here, CXCL8 is linked to anemia.